急性心肌梗死患者血清白三烯B4和基质金属蛋白酶-9表达的变化及其意义

徐晨凯, 刘小伟, 唐礼江, 等. 急性心肌梗死患者血清白三烯B4和基质金属蛋白酶-9表达的变化及其意义[J]. 临床心血管病杂志, 2015, 31(5): 536-538. doi: 10.13201/j.issn.1001-1439.2015.05.018
引用本文: 徐晨凯, 刘小伟, 唐礼江, 等. 急性心肌梗死患者血清白三烯B4和基质金属蛋白酶-9表达的变化及其意义[J]. 临床心血管病杂志, 2015, 31(5): 536-538. doi: 10.13201/j.issn.1001-1439.2015.05.018
XU Chenkai, LIU Xiaowei, TANG Lijiang, et al. Dynamic observation on leukotriene B4 and matrix metalloproteinase-9 levels in patients with acute myocardial infarction[J]. J Clin Cardiol, 2015, 31(5): 536-538. doi: 10.13201/j.issn.1001-1439.2015.05.018
Citation: XU Chenkai, LIU Xiaowei, TANG Lijiang, et al. Dynamic observation on leukotriene B4 and matrix metalloproteinase-9 levels in patients with acute myocardial infarction[J]. J Clin Cardiol, 2015, 31(5): 536-538. doi: 10.13201/j.issn.1001-1439.2015.05.018

急性心肌梗死患者血清白三烯B4和基质金属蛋白酶-9表达的变化及其意义

  • 基金项目:

    浙江省医药卫生科技计划项目(No:2011ZDA028)

详细信息
    作者简介:

    唐礼江,E-mail:taizhoutang@hotmail.com

  • 中图分类号: R542.2

Dynamic observation on leukotriene B4 and matrix metalloproteinase-9 levels in patients with acute myocardial infarction

  • 目的:探讨急性ST段抬高型心肌梗死(STEMI)患者血清白三烯B4(LTB4)和基质金属蛋白酶-9(MMP-9)表达的动态变化及其临床意义。方法:采用酶联免疫吸附法(ELISA)测定40例STEMI患者入院48h及出院后第3个月、6个月血清中LTB4及MMP-9的表达;全自动生化分析仪测定脂蛋白(a)。结果:与入院水平相比,STEMI患者血清LTB4的表达水平在出院后第3个月及第6个月呈持续性下降,结果有统计学意义(P<0.05);出院后第3个月MMP-9的表达显著低于入院时水平(P<0.05),而与第6个月相比差异无统计学意义(P>0.05)。在脂蛋白(a)总体较高25%水平与总体较低25%水平的患者血清中MMP-9的差异有统计学意义(P<0.05)。结论:STEMI患者院外3~6个月随访发现其血清中LTB4和MMP-9的表达呈动态变化,其中LTB4血清水平呈进行性降低,脂蛋白(a)显著增高人群在发生心肌梗死时其MMP-9水平较高。
  • 加载中
  • [1]

    ZHOU G,GE S,LIU D,et al.Atorvastatin reduces plaque vulnerability in an atherosclerotic rabbit model by altering the 5-lipoxygenase pathway[J].Cardiology, 2010,115:221-228.

    [2]

    XU S,TANG L,MI Y,et al.Clinical significance of leukotriene b4 and extracellular matrix metalloproteinase inducer in acute coronary syndrome[J].Clin Invest Med,2013,36:E282-E289.

    [3]

    HLAWATY H,JACOB M P,LOUEDEC L,et al.Leukotriene receptor antagonism and the prevention of extracellular matrix degradation during atherosclerosis and in-stent stenosis[J].Arterioscler Thromb Vasc Biol,2009,29:518-524.

    [4]

    EMERGING RISK FACTORS COLLABORATION,ERQOU S,KAPTOGE S,PERRY P L,et al.Lipoprotein (a) concentration and the risk of coronary heart disease, stroke, and nonvascular mortality[J].JAMA,2009.302:412-423.

    [5]

    SEIMON T A,NADOLSKI M J,LIAO X,et al.Atherogenic lipids and lipoproteins trigger CD36-TLR2-dependent apoptosis in macrophages undergoing endoplasmic reticulum stress[J].Cell Metab,2010,12:467-482.

    [6]

    TSIMIKAS S,BRILAKIS E S,MILLER E R,et al.Oxidized phospholipids, Lp (a) lipoprotein, and coronary artery disease[J].N Engl J Med,2005,353:46-57.

    [7]

    HUANG M,GONG Y,GRONDOLSKY J,et al.Lp (a)/apo (a) modulate MMP-9 activation and neutrophil cytokines in vivo in inflammation to regulate leukocyte recruitment[J].Am J Pathol,2014,184:1503-1517.

  • 加载中
计量
  • 文章访问数:  84
  • PDF下载数:  27
  • 施引文献:  0
出版历程
收稿日期:  2014-07-30

目录